ENTA - Enanta Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$48.20
DETAILS
HIGH:
$87.00
LOW:
$20.00
MEDIAN:
$54.00
CONSENSUS:
$48.20
UPSIDE:
245.52%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Revenue | 65.3 | 67.6 | 79.2 | 86.2 | 97.1 | 122.5 | 205.2 | 206.6 | 102.8 | 88.3 | 160.9 | 47.7 | 32.1 | 41.7 | 41.9 | 22.8 |
| Cost of Revenue | 4.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 60.7 | 67.6 | 79.2 | 86.2 | 97.1 | 122.5 | 205.2 | 206.6 | 102.8 | 88.3 | 160.9 | 47.7 | 32.1 | 41.7 | 41.9 | 22.8 |
| Operating Expenses | ||||||||||||||||
| R&D Expenses | 106.7 | 131.5 | 163.5 | 164.5 | 174.1 | 136.8 | 142.2 | 94.9 | 57.5 | 40.5 | 23.2 | 18.7 | 16.8 | 15.1 | 11.5 | 9.7 |
| SG&A Expenses | 43.9 | 57.9 | 52.9 | 45.5 | 32.5 | 27.4 | 26.2 | 23.4 | 20.7 | 17.0 | 13.5 | 10.0 | 6.2 | 5.3 | 5.0 | 6.1 |
| Other Expenses | (4.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0 | 0 | 0 | 0 |
| Operating Expenses | 146.1 | 189.3 | 216.4 | 210.0 | 206.6 | 164.1 | 168.5 | 118.3 | 78.2 | 57.4 | 36.7 | 28.8 | 23.0 | 20.4 | 16.6 | 15.8 |
| Operating Income | ||||||||||||||||
| Operating Income | (85.3) | (121.7) | (137.2) | (123.8) | (109.6) | (41.6) | 36.7 | 88.3 | 24.6 | 30.8 | 124.1 | 19.0 | 9.0 | 21.3 | 25.3 | 6.9 |
| Interest Expense | 7.7 | 10.9 | 5.1 | 0 | 0 | 0 | 0 | 4.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 3.2 | 0 |
| Interest Income | 9.5 | 14.8 | 11.4 | 1.6 | 2.0 | 6.5 | 8.8 | 0 | 2.5 | 1.7 | 1.0 | 0.5 | 0.2 | 0.1 | 0.1 | 0.0 |
| Profitability | ||||||||||||||||
| EBITDA | (70.8) | (104.5) | (123.5) | (119.2) | (104.2) | (38.0) | 40.0 | 90.8 | 26.8 | 32.5 | 124.8 | 19.3 | 9.2 | 21.6 | 27.0 | 8.3 |
| EBIT | (75.9) | (106.8) | (125.8) | (122.2) | (107.6) | (41.6) | 36.7 | 88.3 | 24.6 | 30.8 | 124.1 | 19.0 | 9.7 | 21.4 | 26.5 | 7.7 |
| Income Before Tax | (83.5) | (117.8) | (131.0) | (122.2) | (107.6) | (35.0) | 45.6 | 93.1 | 26.9 | 32.6 | 125.5 | 19.3 | 9.6 | 21.4 | 23.3 | 7.7 |
| Income Tax Expense | (1.7) | (1.7) | 2.8 | (0.4) | (28.6) | 1.1 | (0.8) | 21.2 | 9.2 | 10.9 | 46.5 | (15.2) | 0 | 0 | 0 | (0.2) |
| Net Income | (81.9) | (116.0) | (133.8) | (121.8) | (79.0) | (36.2) | 46.4 | 72.0 | 17.7 | 21.7 | 79.0 | 34.4 | 9.6 | 21.4 | 23.3 | 7.9 |
| Per Share Data | ||||||||||||||||
| EPS (Basic) | -3.84 | -5.48 | -6.38 | -5.91 | -3.92 | -1.81 | 2.37 | 3.48 | 0.93 | 1.14 | 4.23 | 1.88 | -0.67 | 1.89 | 1.82 | 0.02 |
| EPS (Diluted) | -3.84 | -5.48 | -6.38 | -5.91 | -3.92 | -1.81 | 2.21 | 3.48 | 0.91 | 1.13 | 4.09 | 1.80 | -0.67 | 8.11 | 8.84 | 0.02 |
| Shares Outstanding | 21.3 | 21.2 | 21.0 | 20.6 | 20.2 | 19.9 | 19.6 | 20.6 | 19.1 | 18.9 | 18.7 | 18.4 | 9.8 | 11.3 | 12.8 | 12.7 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 32.3 | 37.2 | 85.4 | 44.0 | 57.2 | 87.1 | 51.2 | 63.9 | 65.7 | 16.6 |
| Short-Term Investments | 156.6 | 211.0 | 284.5 | 205.2 | 186.8 | 299.5 | 284.0 | 244.8 | 158.0 | 193.5 |
| Net Receivables | 6.9 | 38.6 | 39.6 | 49.0 | 60.8 | 23.5 | 51.3 | 67.2 | 10.6 | 12.8 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 8.6 | 0.6 | 13.3 | 0 | 0 | 26.7 | 0 | 4.5 | 3.5 | 9.2 |
| Total Current Assets | 204.3 | 299.9 | 422.8 | 311.7 | 319.0 | 436.8 | 401.8 | 380.4 | 237.8 | 232.2 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 72.9 | 73.3 | 34.7 | 29.7 | 10.7 | 15.6 | 10.9 | 8.4 | 8.0 | 8.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 3.4 | 3.4 | 4.0 | 33.3 | 109.0 | 33.2 | 65.0 | 16.4 | 70.0 | 32.1 |
| Other Non-Current Assets | 0.1 | 0.1 | 0.8 | 0.7 | 0.1 | 0.1 | 0.7 | 0.7 | 0.6 | 0.6 |
| Total Non-Current Assets | 76.4 | 76.8 | 39.5 | 68.9 | 121.8 | 54.0 | 88.0 | 33.8 | 88.8 | 49.1 |
| Total Assets | 280.7 | 376.7 | 462.3 | 380.6 | 440.9 | 490.8 | 489.8 | 414.2 | 326.6 | 281.3 |
| Current Liabilities | ||||||||||
| Account Payables | 1.9 | 8.0 | 4.1 | 6 | 9.5 | 5.7 | 6.7 | 4.7 | 3.7 | 3.4 |
| Short-Term Debt | 30.7 | 34.5 | 0 | 0 | 0 | 4.3 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.3 | 0 |
| Other Current Liabilities | 0 | 0 | 35.1 | 14.5 | 16.3 | 9.4 | 0 | 0 | 9.2 | 0 |
| Total Current Liabilities | 48.6 | 57.5 | 62.8 | 29.8 | 36.2 | 24.2 | 22.6 | 16.0 | 21.0 | 7.9 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 112.4 | 136.1 | 0 | 1.4 | 1.5 | 1.5 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 5.2 | 2.1 | 4.7 | 1.7 | 1.8 | 1.2 | 0.7 |
| Other Non-Current Liabilities | 0.3 | 0.2 | 161.5 | 0.5 | 0.6 | 1.1 | 4.5 | 4.2 | 3.6 | 3.0 |
| Total Non-Current Liabilities | 167.5 | 190.3 | 182.8 | 29.4 | 5.3 | 11.1 | 4.7 | 4.5 | 4.0 | 3.5 |
| Total Liabilities | 216.0 | 247.8 | 245.5 | 59.3 | 41.4 | 35.2 | 27.3 | 20.5 | 25.0 | 11.3 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Retained Earnings | (404.9) | (323.0) | (207.0) | (73.2) | 48.6 | 127.6 | 163.7 | 117.4 | 45.4 | 27.6 |
| Accumulated Other Comprehensive Income | (0.3) | 0.3 | (1.2) | (3.7) | (0.4) | 0.8 | 0.1 | (0.4) | (0.1) | 0.0 |
| Total Stockholders' Equity | 64.7 | 128.8 | 216.7 | 321.3 | 399.4 | 455.6 | 462.5 | 393.7 | 301.7 | 269.9 |
| Total Liabilities & Equity | 280.7 | 376.7 | 462.3 | 380.6 | 440.9 | 490.8 | 489.8 | 414.2 | 326.6 | 281.3 |
| Debt Metrics | ||||||||||
| Total Debt | 201.1 | 226.1 | 26.5 | 26.7 | 6.8 | 9.6 | 0.2 | 0.3 | 0.5 | 0.5 |
| Net Debt | 168.8 | 188.8 | (58.9) | (17.3) | (50.4) | (77.6) | (51.0) | (63.6) | (65.2) | (16.0) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (81.9) | (116.0) | (133.8) | (121.8) | (79.0) | (36.2) | 46.4 | 72.0 | 17.7 | 21.7 |
| Depreciation & Amortization | 5.1 | 2.3 | 2.4 | 3.0 | 3.3 | 3.6 | 3.3 | 2.5 | 2.1 | 1.7 |
| Stock-Based Compensation | 18.6 | 26.8 | 28.2 | 27.0 | 21.0 | 19.6 | 19.2 | 15.8 | 13.1 | 9.4 |
| Change in Working Capital | 39.9 | 7.1 | 8.0 | 6.8 | (13.7) | 12.9 | 11.5 | (61.8) | 22.0 | 6.2 |
| Other Non-Cash Items | (0.9) | 1.0 | (7.9) | 0.2 | (2.0) | (3.5) | (5.8) | (1.2) | (0.6) | (0.7) |
| Operating Cash Flow | (19.3) | (78.8) | (103.2) | (84.8) | (70.0) | 7.1 | 71.4 | 29.2 | 52.7 | 35.8 |
| Investing Activities | ||||||||||
| Capital Expenditure | (12.9) | (17.9) | (9.1) | (2.1) | (0.8) | (1.4) | (5.4) | (3.0) | (2.5) | (4.7) |
| Acquisitions | 0 | 0 | 44.5 | (54.9) | (37.7) | 0 | 86.7 | 0 | 0 | 0 |
| Purchases of Investments | (209.6) | (307.3) | (373.4) | (171.4) | (307.3) | (338.6) | (549.3) | (293.1) | (251.4) | (192.4) |
| Sales/Maturities of Investments | 262.9 | 383.5 | 328.9 | 228.5 | 345.1 | 359.8 | 468.1 | 260.7 | 249.3 | 153.5 |
| Other Investing Activities | 0 | 0 | (44.5) | 54.9 | 37.7 | 0 | 0 | (32.4) | (2.1) | (38.9) |
| Investing Cash Flow | 40.3 | 58.2 | (53.6) | 54.9 | 37.0 | 19.8 | (86.7) | (35.4) | (4.6) | (43.7) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (26.5) | (27.5) | 199.7 | 0 | 0 | 0 | (0.1) | (0.1) | (0.1) | (0.1) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.3) | (0.3) | (3.8) | (1.2) | (0.5) | 9.0 | 2.7 | 4.5 | 1.1 | 2.8 |
| Financing Cash Flow | (26.6) | (27.6) | 198.1 | 20.0 | 3.1 | 9.0 | 2.6 | 4.4 | 1.0 | 2.7 |
| Cash Position | ||||||||||
| Net Change in Cash | (5.5) | (48.2) | 41.4 | (9.9) | (29.9) | 35.9 | (12.7) | (1.8) | 49.1 | (5.1) |
| Cash at Beginning | 41.2 | 89.4 | 48.0 | 57.8 | 87.7 | 51.8 | 64.5 | 65.7 | 16.6 | 21.7 |
| Cash at End | 35.7 | 41.2 | 89.4 | 48.0 | 57.8 | 87.7 | 51.8 | 63.9 | 65.7 | 16.6 |
| Free Cash Flow | (32.2) | (96.7) | (112.2) | (86.9) | (70.7) | 5.6 | 66.0 | 26.2 | 50.1 | 31.1 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||
| Revenue | 65.3 | 67.6 | 79.2 | 86.2 | 97.1 | 122.5 | 205.2 | 206.6 | 102.8 | 88.3 | 160.9 | 47.7 | 32.1 | 41.7 | 41.9 | 22.8 |
| Gross Profit | 60.7 | 67.6 | 79.2 | 86.2 | 97.1 | 122.5 | 205.2 | 206.6 | 102.8 | 88.3 | 160.9 | 47.7 | 32.1 | 41.7 | 41.9 | 22.8 |
| Operating Income | (85.3) | (121.7) | (137.2) | (123.8) | (109.6) | (41.6) | 36.7 | 88.3 | 24.6 | 30.8 | 124.1 | 19.0 | 9.0 | 21.3 | 25.3 | 6.9 |
| Net Income | (81.9) | (116.0) | (133.8) | (121.8) | (79.0) | (36.2) | 46.4 | 72.0 | 17.7 | 21.7 | 79.0 | 34.4 | 9.6 | 21.4 | 23.3 | 7.9 |
| EPS (Diluted) | -3.84 | -5.48 | -6.38 | -5.91 | -3.92 | -1.81 | 2.21 | 3.48 | 0.91 | 1.13 | 4.09 | 1.80 | -0.67 | 8.11 | 8.84 | 0.02 |
| Balance Sheet | ||||||||||||||||
| Cash & Equivalents | 32.3 | 37.2 | 85.4 | 44.0 | 57.2 | 87.1 | 51.2 | 63.9 | 65.7 | 16.6 | ||||||
| Total Assets | 280.7 | 376.7 | 462.3 | 380.6 | 440.9 | 490.8 | 489.8 | 414.2 | 326.6 | 281.3 | ||||||
| Total Debt | 201.1 | 226.1 | 26.5 | 26.7 | 6.8 | 9.6 | 0.2 | 0.3 | 0.5 | 0.5 | ||||||
| Stockholders' Equity | 64.7 | 128.8 | 216.7 | 321.3 | 399.4 | 455.6 | 462.5 | 393.7 | 301.7 | 269.9 | ||||||
| Cash Flow | ||||||||||||||||
| Operating Cash Flow | (19.3) | (78.8) | (103.2) | (84.8) | (70.0) | 7.1 | 71.4 | 29.2 | 52.7 | 35.8 | ||||||
| Capital Expenditure | (12.9) | (17.9) | (9.1) | (2.1) | (0.8) | (1.4) | (5.4) | (3.0) | (2.5) | (4.7) | ||||||
| Free Cash Flow | (32.2) | (96.7) | (112.2) | (86.9) | (70.7) | 5.6 | 66.0 | 26.2 | 50.1 | 31.1 | ||||||